Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa clinical trials

Explore recruiting usher syndrome type 1b ush1b retinitis pigmenotsa clinical trials.

Also recruiting in Europe

Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Multicenter, Open-label, Dose Escalation, Safety and Efficacy Study of Subretinal Administration of Dual AAV8.MYO7A, AAVB-081 in Participants with Usher Syndrome Type 1B (USH1B) Retinitis Pigmentosa

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa trials by city

Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Toronto Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Vancouver Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Montreal Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Calgary Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Edmonton Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Ottawa Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Winnipeg Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Quebec City Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Hamilton Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Kitchener Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in London Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Halifax Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in New York Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Los Angeles Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Chicago Usher Syndrome Type 1b Ush1b Retinitis Pigmenotsa in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease